Cutting Edge Technologies, Inc.
United StatesFDA 510(k) applicant, unverified
- Devices
- 2
What Cutting Edge Technologies, Inc. makes
Cutting Edge Technologies, Inc. manufactures the SERAGARD Vascular Access Device, a solution for securing intravenous lines, and the TARGETT Patch, a wound or incision dressing designed for medical use.
The company’s products are regulated under FDA 510(k) clearance, with devices classified as Class I and Class II. They are listed in the FDA’s 510(k) database and operate from the United States.
Catalogue
Seragard Vascular Access Device Ref K963595
510(k) 510(k)Targett Patch Ref K952606
510(k) 510(k)
Frequently asked questions
How many devices does Cutting Edge Technologies, Inc. have in the registry?
The registry currently lists 2 devices for Cutting Edge Technologies, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Cutting Edge Technologies, Inc.'s devices?
Among its 2 most recently registered devices, Cutting Edge Technologies, Inc. has devices listed in FDA 510(k) (2 devices).
What risk classes do Cutting Edge Technologies, Inc.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Cutting Edge Technologies, Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Cutting Edge Technologies, Inc. in the registry?
The most recently registered devices listed for Cutting Edge Technologies, Inc. include SERAGARD VASCULAR ACCESS DEVICE and TARGETT PATCH.